Nivolumab Monotherapy Is Effective in Japanese mRCC Patients in a Real-World Setting
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
A Multicenter Retrospective Study of Nivolumab Monotherapy in Previously Treated Metastatic Renal Cell Carcinoma Patients: Interim Analysis of Japanese Real-World Data
Int. J. Clin. Oncol. 2020 Jun 09;[EPub Ahead of Print], N Hinata, J Yonese, S Masui, Y Nakai, S Shirotake, K Tatsugami, T Inamoto, M Nozawa, K Ueda, T Etsunaga, T Osawa, M Uemura, G Kimura, K Numakura, K Yamana, H Miyake, S Fukasawa, K Ochi, H Kaneko, H UemuraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.